Search Results - Hongtu Chao

  • Showing 1 - 1 results of 1
Refine Results
  1. 1
    A phase 2 study of tislelizumab combined with bevacizumab and chemotherapy as first-line treatment for persistent, recurrent, or metastatic cervical cancerResearch in context

    A phase 2 study of tislelizumab combined with bevacizumab and chemotherapy as first-line treatment for persistent, recurrent, or metastatic cervical cancerResearch in context by Qiang Wen, Hao Yu, Mei Pan, Hongtu Chao, Yuhua Gao, Shuhuai Niu, Hongqin Zhao, Youguo Chen, Jianqing Zhu

    Published 2025-07-01
    Get full text
    Article

    Save to List
    Saved in:

Search Tools: